Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
WeWork chapter 11 filing
We are advising an ad hoc group of secured noteholders in connection with WeWork’s restructuring
Banco Santander $3.75 billion senior preferred notes
We advised Banco Santander on its investment-grade debt offering
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
GSK collaboration extension and new data licensing agreement with 23andMe
We advised GSK on the transaction
Oesterreichische Kontrollbank $1 billion notes offering
The 5% notes are due 2026
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
MSCI acquisition of Trove Research
We are advising MSCI on the acquisition
Instant Brands sale of substantially all of its assets to Centre Lane Partners
We are advising Instant Brands on the sale
Diageo Capital $1.7 billion notes offering
The investment-grade notes are due 2026 and 2033